Androgenic Alopecia and Subclinical Atherosclerosis: Is There Any Relationship?

January 2017 in “ Journal of clinical & experimental dermatology research ”

Parviz Toosi, Morteza Sanei Taheri, Ommekolsom Eslamnia

androgenetic alopecia AGA vertex alopecia frontal alopecia carotid intima-media thickness IMT androgenic alopecia hair loss atherosclerosis

TLDR There's no significant link between hair loss from male pattern baldness and early heart disease.

The 2017 study "Androgenic Alopecia and Subclinical Atherosclerosis: Is Any Relationship?" involved 94 participants, 47 with androgenetic alopecia (AGA) and 47 controls. The researchers measured the carotid intima-media thickness (IMT), a marker of atherosclerosis, in both groups. The results showed no significant difference in IMT between the AGA group and the control group. However, within the AGA group, those with vertex alopecia had a significantly higher IMT than those with frontal alopecia. Despite this, the difference in IMT between those with vertex alopecia and the controls was not significant. The study concluded that there was no significant increase in IMT in individuals with AGA compared to the controls.

View this study on longdom.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 9 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Dutasteride Isn't Working? Get a Scalp Biopsy NOW

in Finasteride/Dutasteride 19 upvotes 3 months ago

Dutasteride may not be effective for everyone due to underlying issues, suggesting scalp biopsies for further diagnosis. Users discuss using higher doses of dutasteride, topical treatments, minoxidil, and pyrilutamide for hair loss management.

community Why Didn't the Pumkin Seed Oil Study Get More Attention?

in Question 71 upvotes 5 years ago

Pumpkin seed oil showed a 40% increase in hair count, but its effectiveness is questioned due to other ingredients in the supplement. Users discuss its potential compared to finasteride, with some expressing skepticism and others showing interest.

community Evidenced Based Meta-Analyses and Systemic Reviews of Androgenic Alopecia and Treatments

in Research/Science 14 upvotes 5 years ago

Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.

community Be careful when switching from Finasteride to Dutasteride because for more efficacy.

in Finasteride/Dutasteride 13 upvotes 7 months ago

Switching from finasteride to dutasteride may be more effective for hair regrowth due to dutasteride's stronger enzyme inhibition, but combining both drugs could enhance results. Some users report better outcomes with dutasteride, while others recommend a gradual transition to prevent potential hair loss.

community Scalp tension and thickness of the galea aponeurotica, inflammation and potential treatment pathways

in Research/Science 3 years ago

Scalp tension potentially affecting hair loss, and potential treatments for male pattern baldness such as Minoxidil, Finasteride and RU58841. Evidence from a study was discussed which suggests that the cause of MPB lies within the follicle itself and is not dependent on its surrounding environment.

Related Research

6 / 6 results

research The Association of Androgenetic Alopecia with Metabolic Syndrome: A Case Control Study on Iranian Population

January 2019 in “International Journal of Dermatology”

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

research The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study

January 2017 in “IP Indian journal of clinical and experimental dermatology”

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Male Androgenetic Alopecia and Cardiovascular Risk Factors